Xeriant (XERI) Cash & Equivalents (2010 - 2026)

Xeriant has disclosed Cash & Equivalents across 16 years of filings, most recently posting $24560.0 for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $24560.0, down 54.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $24560.0 (down 54.17% YoY), and the FY2025 annual result was $44850.0, down 93.13% from the prior year.
• Cash & Equivalents came in at $24560.0 for Q1 2026 at Xeriant, down from $76533.0 in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $1.7 million in Q1 2022 to a low of $24551.0 in Q3 2023.
• The 5-year median for Cash & Equivalents is $104080.0 (2023), against an average of $319933.9.
• Across the five-year window, Cash & Equivalents plunged 95.07% in 2023 and jumped 1122.04% in 2024, its largest moves.
• Xeriant's Cash & Equivalents stood at $119593.0 in 2022, then sank by 67.41% to $38981.0 in 2023, then soared by 552.1% to $254195.0 in 2024, then sank by 69.89% to $76533.0 in 2025, then slumped by 67.91% to $24560.0 in 2026.
• The last three Cash & Equivalents figures came in at $24560.0 (Q1 2026), $76533.0 (Q4 2025), and $52136.0 (Q3 2025), per Business Quant data.